ClinicalTrials.gg

Novartis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 3,899 studies whose lead sponsor is Novartis or one of 19 companies grouped under it. 211 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 20 registry names, not the registry’s. See them and correct one ↓

Compare Novartis with Pfizer and Hoffmann-La Roche →

Pipeline: 77 programs

Each counted once: 72 with a study Novartis leads registered in the last two years, 5 more from Novartis's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by Novartis only (no registered study yet; not in the 77)

The 5 of 18 with the most live studies.

Program
remibrutinibPhase 3 · 21 live · Chronic Urticaria · primary completion Feb 2027☆ Track
ianalumabPhase 3 · Novartis: Registration · 16 live · Purpura, Thrombocytopenic, Idiopathic · primary completion Mar 2027☆ Track
iptacopanPhase 3 · 12 live · Hemoglobinuria, Paroxysmal · primary completion Dec 2026☆ Track
pelabresibPhase 3 · Novartis: Registration · 7 live · Primary Myelofibrosis · primary completion Mar 2028☆ Track
pelacarsenPhase 3 · 4 live · Cardiovascular Diseases · primary completion Feb 2028☆ Track

13 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Novartis’s own registered studies; “Novartis says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

3 of Novartis’s programs have a dated deal behind them: 2 brought in, 2 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 2

Licensed out 2

What it is testing

The drugs Novartis’s studies test, most open studies first — 426 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 426; every drug is on its own page, and each page lists its sponsors.

Coming up

124 of Novartis’s studies under way reach primary completion within a year, 16 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 5N’26
  2. 21D
  3. 13J’27
  4. 10F
  5. 8M
  6. 13A
  7. 10M
  8. 9J
  9. 9J
  10. 8A
  11. 7S
  12. 6O
  13. 5N

The 12 nearest

Show 7 more

Add all 124 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

Newly registered11

Show 6 more

All 3,899 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2115%Recruiting 182 · Not yet recruiting 28 · Enrolling by invitation 1
  • Under way, not recruiting1654%
  • Completed2,91675%
  • Stopped early55714%Terminated 440 · Withdrawn 116 · Suspended 1
  • Status unknown or other501%No longer available 30 · Available 14 · Approved for marketing 5 · Temporarily not available 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 21410
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 11426

By the year each study started; 879 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Novartis.

  • Novartis Pharmaceuticals
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2,720 studies →
  • Novartis
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    714 studies
  • Novartis Vaccines
    Divested — left Novartis, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    165 studies →
  • Sandoz
    Divested — left Novartis, Oct 4, 2023 · 5 more first submitted after it left, not counted · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    134 studies →
  • The Medicines Company
    Acquired — became part of Novartis, Jan 6, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    50 studies →
  • Endocyte
    Acquired — became part of Novartis, Dec 21, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    29 studies →
  • Advanced Accelerator Applications
    Acquired — became part of Novartis, Jan 22, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Alcon, a Novartis Company
    Divested — left Novartis, Apr 9, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • Avidity Biosciences, Inc.
    Acquired — became part of Novartis, Feb 27, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • MorphoSys AG
    Acquired — became part of Novartis, May 23, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Novartis Gene Therapies
    Acquired — became part of Novartis, May 15, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
    Acquired — became part of Novartis, Jan 6, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
    Acquired — became part of Novartis, Feb 3, 2010 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Chinook Therapeutics, Inc.
    Acquired — became part of Novartis, Aug 11, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Regulus Therapeutics Inc.
    Acquired — became part of Novartis, Jun 25, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Chinook Therapeutics, Inc. (formerly Aduro)
    Acquired — became part of Novartis, Aug 11, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Tourmaline Bio, Inc., a Novartis Company
    Acquired — became part of Novartis, Oct 28, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Novartis Korea Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Novartis Slovakia, s.r.o.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Novartis Healthcare A/S
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Novartis leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 138 areas
Renal Insufficiency36Alzheimer Disease35Leukemia35Multiple Sclerosis, Relapsing-Remitting34Precursor Cell Lymphoblastic Leukemia-Lymphoma33Cardiovascular Diseases32Hypercholesterolemia32Iron Overload32Meningitis, Meningococcal32Arthritis, Psoriatic31Dermatitis, Atopic31Lymphoma, Large B-Cell, Diffuse31Arthritis, Rheumatoid30Colorectal Neoplasms30Osteoporosis30Macular Edema29Meningitis28Renal Insufficiency, Chronic28Vision Disorders28Atherosclerosis27Choroidal Neovascularization27Essential Hypertension27Anemia, Sickle Cell25Gastrointestinal Stromal Tumors25Osteoarthritis25Depression24Lymphoma, Follicular24Malaria24Primary Myelofibrosis24Ovarian Neoplasms23Dyslipidemias22Glioblastoma22Hepatitis B, Chronic21Hidradenitis Suppurativa21Spondylitis, Ankylosing21Triple Negative Breast Neoplasms21Cystic Fibrosis20Lymphoma20Parkinson Disease20Retinal Vein Occlusion20Anemia19Carcinoma19Lymphoma, Non-Hodgkin19Arthritis, Juvenile18Glomerulonephritis, IGA18Hematologic Neoplasms18Muscular Atrophy, Spinal18Neuroendocrine Tumors18Pain18Thalassemia18Bronchiolitis Obliterans Syndrome17Dermatitis17Purpura, Thrombocytopenic, Idiopathic17Acromegaly16Adenocarcinoma of Lung16Arthritis16Hemoglobinuria, Paroxysmal16Multiple Sclerosis, Chronic Progressive16Obesity16Brain Neoplasms15Myocardial Infarction15Pruritus15Adenocarcinoma14Anemia, Aplastic14Diabetic Retinopathy14Dyspnea14Geographic Atrophy14Lupus Erythematosus, Systemic14Migraine Disorders14Sjogren's Syndrome14Wet Macular Degeneration14COVID-1913Dementia13Hyperlipidemias13Hypersensitivity13Kidney Diseases13Leukemia, Lymphocytic, Chronic, B-Cell13Osteoarthritis, Knee13Pancreatic Neoplasms13Small Cell Lung Carcinoma13Burkitt Lymphoma12Cryopyrin-Associated Periodic Syndromes12Diarrhea12Dyskinesias12Endometrial Neoplasms12Malaria, Falciparum12Metabolic Syndrome12Muscular Atrophy12Polycythemia Vera12Proteinuria12Pulmonary Arterial Hypertension12Stomach Neoplasms12Acute Coronary Syndrome11Autoimmune Diseases11Bone Diseases, Metabolic11Depressive Disorder, Major11Eczema11Eye Diseases11Graft vs Host Disease11Hepatitis B11HIV Infections11Rhinitis, Allergic, Seasonal11Uveitis11Attention Deficit Disorder with Hyperactivity10beta-Thalassemia10Colonic Neoplasms10Coronary Artery Disease10Hepatitis C10Infections10Kidney Neoplasms10Lupus Nephritis10Philadelphia Chromosome10Schizophrenia10Seizures10

Studies

Recruiting first, then most recently updated. Showing 50 of 3,899. Browse all 3,899 →